ClinicalTrials.Veeva

Menu

Realistic in Generation of HEp-2 Cell Images Using Latent Diffusion Models: a Multi-center Visual Turing Test

Shanghai Jiao Tong University logo

Shanghai Jiao Tong University

Status

Not yet enrolling

Conditions

Artifical Intelligence
Anti-nuclear Antibody
Visual Turing Tests

Treatments

Behavioral: referring to the results of AI model output

Study type

Observational

Funder types

Other

Identifiers

NCT06542783
XH-24-007

Details and patient eligibility

About

The objective of this prospective observational study is to rigorously examine the feasibility and efficacy of utilizing latent diffusion models for data augmentation in anti-nuclear antibody (ANA) Hep-2 cell immunofluorescence images. The main question it aims to answer is:

Can the application of such models potentially enhance the data quality, increase sample diversity, or improve the accuracy and efficiency of subsequent analytical processes (like disease diagnosis and classification) when utilized with ANA-related images?

Full description

A fundamental problem in biomedical research is the low number of observations available, mostly due to a lack of available biosamples, prohibitive costs, or ethical reasons. Augmenting few real observations with generated in silico samples could lead to more robust analysis results and a higher reproducibility rate. Here, The investigators propose to use unsupervised learning with latent diffusion models for the realistic generation of ANA-IIF image data.

The investigators hypothesize that the the generation of ANA-IIF image will be realistic if it is hard to differentiate them (fake) from real (true) . To test this hypothesis, the investigators present a Multi-center Visual Turing tests (https://turing.rednoble.net/) in order to evaluate the quality of the generated (fake) images.

This experimental setup allows the investigators to validate the overall quality of the generated ANA-IIF images, which can then be used to (1) train cytopathologists for educational purposes, and (2) generate realistic samples to train deep networks with big data.

Enrollment

300 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Originating from reputable medical institutions
  • Possessing relevant certification and qualifications
  • Having over one year of experience in interpreting anti-nuclear antibody (ANA) patterns within a laboratory setting

Exclusion criteria

  • Lacking relevant professional certification and qualifications
  • Without experience in interpreting ANA patterns
  • Unwilling to accept the rules and informed consent of the visual Turing test

Trial design

300 participants in 2 patient groups

experts
Description:
with over 20 years of experience in ANA-IIF reading
Treatment:
Behavioral: referring to the results of AI model output
junior cytopathologists
Description:
less than 5 years of academic medical experience
Treatment:
Behavioral: referring to the results of AI model output

Trial documents
1

Trial contacts and locations

0

Loading...

Central trial contact

Junxiang Zeng, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems